Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.49443 | 20 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.45159 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44307 | 18 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41636 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.40676 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.47857 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.63636 | 26 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43336 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.42864 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.41469 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.43553 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43035 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43884 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.4431 | 19 |